The organizing Goal of Project 2 is to understand how the physicochemical composition and structure of engineered nanoparticles (ENPs) dictate ENP biokinetics and biological response in mice. This research will be conducted using custom-designed materials that contain a super paramagnetic iron oxide core, fluorescent labels, and functionalized to provide a range of net charges.
In Aim 1 we will characterize the biokinetics of funcfionalized iron, cerium, and silica oxides following inhalation exposure using a novel Magnetic Particle Detection system and fluorescence microscopy for quantitation and localizafion of the ENPs. The biokinetic results will be formalized in a Physiologically-Based Pharmacokinetic model.
In Aim 2 we hypothesize that genetic defects in the reficuloendothelial system, (loss of scavenger receptors) will modify the tissue/cellular biokinetics of ENPs according to their size and net charge. We also propose that the tissue/cell dose and biokinetics of ENPs in mice will be perturbed by perturbafion of pulmonary function via structural changes in the lower respiratory tract. The consequences of these genotype and phenotype modifications on nanoparticle biokinefics should be reflected by changes in the inflammatory response.
Aim 3 will relate these biokinetic and biochemical results to altered susceptibility to pulmonary infecfion by Streptococcus pneumoniae. The results from Project #2 will provide the critical experimental link between the in vitro mechanistic focus of Project #1 and the risk assessment focus of Project #3. This link is facilitated by use of highly parallel experimental systems, test materials, biological response assays, and statistical approaches to rank response across levels of biological organization. This Project is innovative for its focus on susceptibillty and clinically important endpoints.
Human exposure air pollution particulates are associated with increased hospitalization due to lung infections. The potential of inhaled engineered nanomaterials to increase susceptibility to pulmonary infections has received surprisingly little attention. This Project will determine how the physicochemical properties of nanomaterials interact with the biokinetics and inflammatory response altering susceptibility to pulmonary infection.
|Duan, Jicheng; Kodali, Vamsi K; Gaffrey, Matthew J et al. (2016) Quantitative Profiling of Protein S-Glutathionylation Reveals Redox-Dependent Regulation of Macrophage Function during Nanoparticle-Induced Oxidative Stress. ACS Nano 10:524-38|
|Baer, Donald R; Munusamy, Prabhakaran; Thrall, Brian D (2016) Provenance information as a tool for addressing engineered nanoparticle reproducibility challenges. Biointerphases 11:04B401|
|Wang, Yung-Chen; Engelhard, Mark H; Baer, Donald R et al. (2016) Quantifying the Impact of Nanoparticle Coatings and Nonuniformities on XPS Analysis: Gold/Silver Core-Shell Nanoparticles. Anal Chem 88:3917-25|
|Holland, Nathan A; Thompson, Leslie C; Vidanapathirana, Achini K et al. (2016) Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury. Part Fibre Toxicol 13:48|
|Cartwright, Megan M; Schmuck, Stefanie C; Corredor, Charlie et al. (2016) The pulmonary inflammatory response to multiwalled carbon nanotubes is influenced by gender and glutathione synthesis. Redox Biol 9:264-275|
|Baer, Donald R; Wang, Yung-Cheng; Castner, David G (2016) Use of XPS to Quantify Thickness of Coatings on Nanoparticles. Micros Today 24:40-45|
|Szymanski, Craig J; Munusamy, Prabhakaran; Mihai, Cosmin et al. (2015) Shifts in oxidation states of cerium oxide nanoparticles detected inside intact hydrated cells and organelles. Biomaterials 62:147-54|
|Munusamy, Prabhakaran; Wang, Chongmin; Engelhard, Mark H et al. (2015) Comparison of 20?nm silver nanoparticles synthesized with and without a gold core: Structure, dissolution in cell culture media, and biological impact on macrophages. Biointerphases 10:031003|
|Scoville, David K; White, Collin C; Botta, Dianne et al. (2015) Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains. Toxicol Appl Pharmacol 289:240-50|
|Holland, N A; Becak, D P; Shannahan, Jonathan H et al. (2015) Cardiac Ischemia Reperfusion Injury Following Instillation of 20 nm Citrate-capped Nanosilver. J Nanomed Nanotechnol 6:|
Showing the most recent 10 out of 29 publications